Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.

Anna LinFrankie W T ChengAlan K S ChiangChung-Wing LukRever C H LiAlvin S C LingDaniel K L CheukKai-On ChangDennis Tak-Loi KuVincent LeeShau-Yin HaChi-Kong Li

Published in: Pediatric blood & cancer (2018)

This population-based study over the past 20 years demonstrated that patients with TCF3-PBX1 rearrangement had favourable EFS compared with other intermediate risk patients treated with a similar chemotherapy backbone.

Keyphrases

liver failure
respiratory failure
drug induced
locally advanced
intensive care unit
chemotherapy induced